SEPROT
  • CURSOS Y CONGRESOS
  • TRABAJO
  • BECAS
  • PUBLICACIONES
  • QUIÉNES SOMOS
  • SOCIOS

Article: Integrative Multi-omics Analysis to Characterize Human Brain Ischemia from García-Berrocoso’s Lab (VHIR – CSIC – UAB)

6 May, 2021Newsadmin

Integrative Multi-omics Analysis to Characterize Human Brain Ischemia
Laura Ramiro, Teresa García-Berrocoso, Ferran Briansó, Leire Goicoechea, Alba Simats, Víctor Llombart, Ricardo Gonzalo, Alexandre Hainard, Elena Martínez-Saez, Francesc Canals, Jean-Charles Sanchez, Alex Sánchez-Pla & Joan Montaner

Molecular Neurobiology (2021); DOI: s12035-021-02401-1

Abstract:

Stroke is a major cause of death and disability. A better comprehension of stroke pathophysiology is fundamental to reduce its dramatic outcome. The use of high-throughput unbiased omics approaches and the integration of these data might deepen the knowledge of stroke at the molecular level, depicting the interaction between different molecular units. We aimed to identify protein and gene expression changes in the human brain after ischemia through an integra- tive approach to join the information of both omics analyses. The translational potential of our results was explored in a pilot study with blood samples from ischemic stroke patients. Proteomics and transcriptomics discovery studies were performed in human brain samples from six deceased stroke patients, comparing the infarct core with the corresponding contralateral brain region, unveiling 128 proteins and 2716 genes significantly dysregulated after stroke. Integrative bioinformatics analyses joining both datasets exposed canonical pathways altered in the ischemic area, highlighting the most influential molecules. Among the molecules with the highest fold-change, 28 genes and 9 proteins were selected to be validated in five independent human brain samples using orthogonal techniques. Our results were confirmed for NCDN, RAB3C, ST4A1, DNM1L, A1AG1, A1AT, JAM3, VTDB, ANXA1, ANXA2, and IL8. Finally, circulating levels of the validated proteins were explored in ischemic stroke patients. Fluctuations of A1AG1 and A1AT, both up-regulated in the ischemic brain, were detected in blood along the first week after onset. In summary, our results expand the knowledge of ischemic stroke pathology, revealing key molecules to be further explored as biomarkers and/or therapeutic targets.

Enlace: DOI: s12035-021-02401-1

Previous post Article: Phosphoproteomic Analysis of Platelets in Severe Obesity Uncovers Platelet Reactivity and Signaling Pathways Alterations, A. García’s Lab (USC) Next post Postdoctoral position at UC Dublin

ESTAMOS EN

Facebook
Twitter

LO ÚLTIMO

  • VII Meeting for young proteomics researchers
  • Article: Multiomics Profiling of Alzheimer’s Disease Serum for the Identification of Autoantibody Biomarkers. R Barderas’s Lab (ISCIII)
  • Article: Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer’s disease. E Santamaría’s Lab (UPNA-IdiSNA)

OFERTAS DE TRABAJO

  • Postdoc SUMO & Ubiquitin in the Cell Cycle – Leiden University Medical Center
  • Postdoc functional proteomics and cell signaling, Blagoy-Blagoev Lab, SDU – Denmark
  • Postdoc at MC Durán Lab, INIBICA-UCA, Cádiz

CURSOS Y CONGRESOS

  • VII Meeting for young proteomics researchers
  • Weminar: Infection Medicine, New-old approaches & perspectives

CONTACT

Sociedad Española de Proteómica C/. Jaime Roig 11 46010 Valencia
secretaria@seprot.es

ESTAMOS EN

Facebook
Twitter

SOCIAL NETWORKS

Facebook
Twitter

ARCHIVO

Desde 2005…

NEWS

  • VII Meeting for young proteomics researchers
  • Article: Multiomics Profiling of Alzheimer’s Disease Serum for the Identification of Autoantibody Biomarkers. R Barderas’s Lab (ISCIII)
  • Article: Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer’s disease. E Santamaría’s Lab (UPNA-IdiSNA)

LINKS

EuPa
Aviso Legal | Diseño Prisma
Esta web utiliza cookies para mejorar su experiencia Acepto Leer más
Política de cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT